Please use this identifier to cite or link to this item:
Authors: Sandeep
Advisor: Rakha, N.K.
Title: Development of Recombinant antigen based ELISA for Serodiagnosis of Theileria equi in equines
Publisher: LUVAS
Language: en
Type: Thesis
Keywords: Theileria equi, Babesia equi, ELISA, EMA-1, Expressed protein, Fusion protein, Equine piroplasmosis, Antibodies, Serodiagnosis
Abstract: The erythrocytic-stage surface protein, Equi Merozoite Antigen 1 (EMA-1), is a major candidate for the development of a immunodiagnostic antigen forTheileria equiinfection . In order to establish an effective diagnostic method for laboratory use, 547bp gene segment of EMA-1 of Theileria equi from Indian isolate was expressed in Escherichia coli as a Glutathione-S-transferase-tagged protein (GSTEMA-1) and the fusion protein was purified by Glutathione sepharose beads. The expressed fusion protein reacted with specific antibodies in Western blot and had an apparent molecular mass of 43 kDa which was largely consistent with its theoretical value. The recombinant purified GST-EMA-1 protein was used in enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against T. equi in horses. The ELISA clearly differentiated T. equi-infected from normal horse sera. Field serum samples collected from horses in Haryana and Uttarakhand, were examined for the determination of T. equi antibodies in ELISA. Of 240 samples analyzed, 45.41% (106/240) were positive for T. equi infection. These results suggest that the GST-EMA-1 protein expressed in E. coli could be a reliable immunodiagnostic antigen for ELISA and that T. equi infection is endemic in the areas from which samples were collected.
Subject: Veterinary Medicine
Theme: Development of Recombinant antigen based ELISA for Serodiagnosis of Theileria equi in equines
These Type: M.V.Sc.
Issue Date: 2012
Appears in Collections:Thesis

Files in This Item:
File Description SizeFormat 
  Restricted Access
937.55 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.